Radiation Modalities For Different Tumors
Coprovided by Meniscus Educational Institute 
and OncUView.tv 
Supported by OncUView.tv
Release Date: September 2010 (Updated October 2011)
CE Available Until: September 30, 2012
Intended Audience
This continuing education activity is designed for oncology nurses and other health care providers interested in the care of oncology patients.
Learning Objectives
At the completion of this activity, participants should be better able to
- Explain the underlying principles of radiobiology by understanding how radiation works to kill cancer cells
- Define terminology utilized in radiation oncology
- Explain different radiation modalities and the clinical applications (tumor types)
- Apply their knowledge to clinical nursing practice when teaching patients about radiation treatments
Rationale and Purpose
The overall purpose of this activity is to provide an overview of the principles of radiation therapy, the variety of radiation treatment modalities, and clinical applications of each. The majority of cancer patients will receive some form of radiation during their continuum of care. Therefore, it is important for all oncology nurses to have a basic understanding of radiation therapy.
Continuing Education
Statement of Credit—Participants who successfully complete this activity (including scoring at least 70% on the learning assessment and completing and submitting the evaluation form) and provide an e-mail address will receive an immediate e-mail notification with a link to a printable statement of credit.
Nurses: This activity for 0.6 contact hours is provided by the Meniscus Educational Institute.
The Meniscus Educational Institute is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Accreditation refers to recognition of educational activities only and does not imply approval or endorsement by the Meniscus Educational Institute or the American Nurses Credentialing Center’s Commission on Accreditation of any product mentioned.
Provider approved by the California Board of Registered Nursing, Provider No. 13164, for 0.6 contact hours.
Financial Disclosures
All individuals in positions to control the content of this program (eg, planners, faculty, content reviewers) are expected to disclose all financial relationships with commercial interests that may have a direct bearing on the subject matter of this continuing education activity. Participants have the responsibility to assess the impact (if any) of the disclosed information on the educational value of the activity. All faculty have been offered a modest honorarium from the accredited provider for their participation in this activity.
Marilyn Haas, PhD, ANP-C, Faculty, receives honoraria from Meda Pharmaceuticals.
Karen Abbas, RN, MS, AOCN, Nursing Education Director, has nothing to disclose.
Linda J. Smith, MSN, MEd, Pilot Study Reviewer, has nothing to disclose.
Randa Sperling, RN, BC, MSN, Pilot Study Reviewer, has nothing to disclose.
Disclaimer
This activity has been designed to provide continuing education that is focused on specific objectives. In selecting educational activities clinicians should pay special attention to the relevance of those objectives and the application to their particular needs. The intent of all Meniscus Educational Institute educational opportunities is to provide learning that will improve patient care. Clinicians are encouraged to reflect on this activity and its applicability to their own patient population.
The opinions expressed in this activity are those of the faculty and reviewers and do not represent an endorsement by MEI of any specific therapeutics or approaches to diagnosis or patient management.
Product Disclosure
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the US Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product.
There is no fee for participating in this activity.
ANCC Accreditation Feedback Line
1-866-262-9730
The Accreditation Program of the American Nurses Credentialing Center is interested in the opinions and perspectives of the participants in accredited continuing nursing education activities, particularly perspectives related to the presence of perceived bias* in an activity. For this reason, we provide a toll-free telephone number, which participants may call at any time to tell us about
· Any noted bias or conflict of interest in the education
· Any concerns, compliments, or opinions
· A great experience
· An unpleasant experience
· Your thoughts on the process
Just call and tell us!
1-866-262-9730
*Bias is defined as preferential influence that causes a distortion of opinion or facts. Commercial bias may occur when an educational activity promotes one or more product(s) (drugs, devices, services, software, hardware, etc). This definition is not all inclusive, and participants may use their own interpretation in deciding whether a presentation is biased.
NOTE: statements of commercial support and/or conflict of interest disclosures do not represent bias. Such statements inform the learner that the provider has implemented a mechanism to identify and resolve all conflicts of interest prior to delivery of the educational material.
Course Materials
Instructions for Completion
To successfully complete this activity and receive continuing education credit, you participate in the activity, score at least 70% on the learning assessment, and complete the evaluation form. You can access the learning assessment and evaluation form by selecting the link below. If you provide your e-mail address, you will receive an immediate e-mail notification with a link to your printable statement of credit.